Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motomu Hashimoto

Showing results (31-40 of 221) with videos related to

Pageof 23
Sort By:
Plos One|July 12, 2019
Metabolomic approach to the exploration of biomarkers associated with disease activity in rheumatoid arthritisChiyomi Sasaki, Tomoko Hiraishi, Takuma Oku, et al.
International Journal of Molecular Sciences|March 29, 2023
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 UpdateQuang Minh Dang, Ryu Watanabe, Mayu Shiomi, et al.
Rheumatology (Oxford, England)|March 26, 2025
Ozoralizumab shows effectiveness regardless of baseline RF and ACPA titres in patients with RA: A post hoc analysis of the OHZORA trialRyu Watanabe, Yoshiya Tanaka, Tsutomu Takeuchi, et al.
Modern Rheumatology|February 22, 2019
Activated neutrophil carbamylates albumin <i>via</i> the release of myeloperoxidase and reactive oxygen species regardless of NETosisShuichiro Nakabo, Koichiro Ohmura, Shuji Akizuki, et al.
Internal Medicine (Tokyo, Japan)|June 16, 2016
Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease PatientsHideaki Tsuji, Koichiro Ohmura, Ran Nakashima, et al.
Seminars in Arthritis and Rheumatism|February 27, 2019
Anti-nuclear antibody development is associated with poor treatment response to biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritisYuki Ishikawa, Motomu Hashimoto, Hiromu Ito, et al.
Plos One|September 20, 2016
Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center CohortYuki Ishikawa, Takao Fujii, Seiko Kondo Ishikawa, et al.
International Journal of Rheumatic Diseases|May 18, 2019
Evaluation of risk factors for atherosclerosis using carotid ultrasonography in Japanese patients with rheumatoid arthritisHiroko Yamamoto, Toshiki Nakajima, Rie Kawahara, et al.
Scientific Reports|December 16, 2016
Relationship between handedness and joint involvement in rheumatoid arthritisAi Yaku, Motomu Hashimoto, Moritoshi Furu, et al.
Scientific Reports|May 4, 2022
Machine learning-based prediction of relapse in rheumatoid arthritis patients using data on ultrasound examination and blood testHidemasa Matsuo, Mayumi Kamada, Akari Imamura, et al.
Pageof 23

Showing results (31-40 of 221) with videos related to

Sort By:
Pageof 23
Plos One|July 12, 2019
Metabolomic approach to the exploration of biomarkers associated with disease activity in rheumatoid arthritisChiyomi Sasaki, Tomoko Hiraishi, Takuma Oku, et al.
International Journal of Molecular Sciences|March 29, 2023
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 UpdateQuang Minh Dang, Ryu Watanabe, Mayu Shiomi, et al.
Rheumatology (Oxford, England)|March 26, 2025
Ozoralizumab shows effectiveness regardless of baseline RF and ACPA titres in patients with RA: A post hoc analysis of the OHZORA trialRyu Watanabe, Yoshiya Tanaka, Tsutomu Takeuchi, et al.
Modern Rheumatology|February 22, 2019
Activated neutrophil carbamylates albumin <i>via</i> the release of myeloperoxidase and reactive oxygen species regardless of NETosisShuichiro Nakabo, Koichiro Ohmura, Shuji Akizuki, et al.
Internal Medicine (Tokyo, Japan)|June 16, 2016
Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease PatientsHideaki Tsuji, Koichiro Ohmura, Ran Nakashima, et al.
Seminars in Arthritis and Rheumatism|February 27, 2019
Anti-nuclear antibody development is associated with poor treatment response to biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritisYuki Ishikawa, Motomu Hashimoto, Hiromu Ito, et al.
Plos One|September 20, 2016
Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center CohortYuki Ishikawa, Takao Fujii, Seiko Kondo Ishikawa, et al.
International Journal of Rheumatic Diseases|May 18, 2019
Evaluation of risk factors for atherosclerosis using carotid ultrasonography in Japanese patients with rheumatoid arthritisHiroko Yamamoto, Toshiki Nakajima, Rie Kawahara, et al.
Scientific Reports|December 16, 2016
Relationship between handedness and joint involvement in rheumatoid arthritisAi Yaku, Motomu Hashimoto, Moritoshi Furu, et al.
Scientific Reports|May 4, 2022
Machine learning-based prediction of relapse in rheumatoid arthritis patients using data on ultrasound examination and blood testHidemasa Matsuo, Mayumi Kamada, Akari Imamura, et al.
Pageof 23